274 related articles for article (PubMed ID: 11115581)
1. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U
Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581
[TBL] [Abstract][Full Text] [Related]
2. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
[TBL] [Abstract][Full Text] [Related]
3. gp100 mRNA is more sensitive than tyrosinase mRNA for RT-PCR amplification to detect circulating melanoma cells in peripheral blood of melanoma patients.
Tsukamoto K; Ueda M; Hirata S; Osada A; Kitamura R; Takahashi T; Ichihashi M; Shimada S
J Dermatol Sci; 2000 Jun; 23(2):126-31. PubMed ID: 10808130
[TBL] [Abstract][Full Text] [Related]
4. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.
Keilholz U; Goldin-Lang P; Bechrakis NE; Max N; Letsch A; Schmittel A; Scheibenbogen C; Heufelder K; Eggermont A; Thiel E
Clin Cancer Res; 2004 Mar; 10(5):1605-12. PubMed ID: 15014010
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.
Rappl G; Hasselmann DO; Rössler M; Ugurel S; Tilgen W; Reinhold U
Ann N Y Acad Sci; 2001 Sep; 945():189-91. PubMed ID: 11708477
[TBL] [Abstract][Full Text] [Related]
6. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
7. Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.
Palmieri G; Strazzullo M; Ascierto PA; Satriano SM; Daponte A; Castello G
J Clin Oncol; 1999 Jan; 17(1):304-11. PubMed ID: 10458247
[TBL] [Abstract][Full Text] [Related]
8. Facts and pitfalls in the detection of tyrosinase mRNA in the blood of melanoma patients by RT-PCR.
Seiter S; Rappl G; Tilgen W; Ugurel S; Reinhold U
Recent Results Cancer Res; 2001; 158():105-12. PubMed ID: 11092037
[TBL] [Abstract][Full Text] [Related]
9. Increased sensitivity for the detection of malignant melanoma cells in peripheral blood using an improved protocol for reverse transcription-polymerase chain reaction.
Schittek B; Blaheta HJ; Flörchinger G; Sauer B; Garbe C
Br J Dermatol; 1999 Jul; 141(1):37-43. PubMed ID: 10417513
[TBL] [Abstract][Full Text] [Related]
10. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the sequential detection of circulating melanoma cells by RT-PCR in high-risk melanoma patients receiving adjuvant interferon.
Gogas H; Kefala G; Bafaloukos D; Frangia K; Polyzos A; Pectasides D; Tsoutsos D; Panagiotou P; Ioannovich J; Loukopoulos D
Br J Cancer; 2002 Jul; 87(2):181-6. PubMed ID: 12107840
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.
Kunter U; Buer J; Probst M; Duensing S; Dallmann I; Grosse J; Kirchner H; Schluepen EM; Volkenandt M; Ganser A; Atzpodien J
J Natl Cancer Inst; 1996 May; 88(9):590-4. PubMed ID: 8609659
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
Brownbridge GG; Gold J; Edward M; MacKie RM
Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
[TBL] [Abstract][Full Text] [Related]
14. Quantitative RT-PCR assessment of melanoma cells in peripheral blood during immunotherapy for metastatic melanoma.
Schmidt H; Sørensen BS; von der Maase H; Bang C; Agger R; Hokland M; Nexo E
Melanoma Res; 2002 Dec; 12(6):585-92. PubMed ID: 12459648
[TBL] [Abstract][Full Text] [Related]
15. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression.
Reinhold U; Lüdtke-Handjery HC; Schnautz S; Kreysel HW; Abken H
J Invest Dermatol; 1997 Feb; 108(2):166-9. PubMed ID: 9008229
[TBL] [Abstract][Full Text] [Related]
16. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
[TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model.
Tsukamoto K; Hirata S; Osada A; Kitamura R; Shimada S
Pigment Cell Res; 2000 Jun; 13(3):185-9. PubMed ID: 10885678
[TBL] [Abstract][Full Text] [Related]
19. What is the role of sequential reverse-transcriptase polymerase chain reaction analysis of melanoma-specific mRNA in the peripheral blood of melanoma patients?
Quaglino P; Osella-Abate S; Savoia P; Bernengo MG; Cappello N; Cavallo F
J Clin Oncol; 2007 Mar; 25(9):1140-1; author reply 1141-2. PubMed ID: 17369579
[No Abstract] [Full Text] [Related]
20. MART-1/Melan-A and tyrosinase transcripts in peripheral blood of melanoma patients: PCR analyses and follow-up testing in relation to clinical stage and disease progression.
Strohal R; Mosser R; Kittler H; Wolff K; Jansen B; Brna C; Stingl G; Pehamberger H
Melanoma Res; 2001 Oct; 11(5):543-8. PubMed ID: 11595894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
